MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer

por En-Chi Hsu, Michelle Shen, Merve Aslan, Shiqin Liu, Manoj Kumar, Fernando Garcia-Marques, Holly M. Nguyen, Rosalie Nolley, Sharon J. Pitteri, Eva Corey, James D. Brooks, Tanya Stoyanova
Publicado 2021

Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay

por Shiqin Liu, Fernando Garcia-Marques, Chiyuan Amy Zhang, Jordan John Lee, Rosalie Nolley, Michelle Shen, En-Chi Hsu, Merve Aslan, Kashyap Koul, Sharon J. Pitteri, James D. Brooks, Tanya Stoyanova
Publicado 2021